Concepedia

Publication | Open Access

Programmed Death Ligand 1 Is Expressed by Non–Hodgkin Lymphomas and Inhibits the Activity of Tumor-Associated T Cells

DOIFull Paper Access

326

Citations

42

References

2011

Year

David Andorsky, Reiko Yamada, Jonathan Said, Geraldine S. Pinkus, David J. Betting, John M. Timmerman
Clinical Cancer Research

Abstract

PD-L1 may thwart effective antitumor immune responses and represents an attractive target for lymphoma immunotherapy.

References

YearCitations

Page 1